| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.0008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |